Home > Press > Probes shed new light on Alzheimer’s cause: Rice University scientists synthesize fluorescent ruthenium tags to track toxic amyloids in lab
A ruthenium-based tag developed at Rice University takes advantage of fluorescent anisotropy to measure the rotation of amyloid beta oligomers as they grow in solution. Small aggregates rotate fast, while large oligomers rotate slowly, a characteristic that lets researchers watch as they grow. Amyloid beta oligomers are toxic to neurons and implicated as a possible cause of Alzheimer’s disease. (Credit: Angel Mart Group/Rice University) |
Abstract:
Rice University researchers have found a way to track the formation of soluble amyloid beta peptide aggregates implicated in the onset of Alzheimer’s disease.
Probes shed new light on Alzheimer’s cause: Rice University scientists synthesize fluorescent ruthenium tags to track toxic amyloids in lab
Houston, TX | Posted on September 27th, 2019
The Rice lab of Angel Mart reported its development of a ruthenium-based fluorescent complex that binds to soluble, oligomeric amyloid beta peptides. As the peptides come together to form the large biomolecules called oligomers, the fluorescent additive binds and labels them.
That will allow researchers to easily track the progress and movements of aggregates as they grow over time. Details of the work appear in the Journal of the American Chemical Society.
Amyloid plaques have long been suspected as the root cause of Alzheimer’s, but recent studies suggest that oligomers floating molecules with repeating peptide units do far more damage.
“There’s a view in the field that soluble oligomers are the main cause of neuronal degeneration, because these oligomers are toxic to neurons,” said Mart, an associate professor of chemistry, of bioengineering and of materials science and nanoengineering. “These oligomers are definitely associated with Alzheimers pathology, so there’s been a need for tools to help us study them.”
He said oligomers are “virtually invisible” to Thioflavin T dyes commonly used to tag amyloid fibrils in lab studies. The ruthenium complexes solve that problem.
The complexes take advantage of fluorescence anisotropy, in which the fluorescent response is polarized, glowing brighter in some directions than others. “It’s a very old technique related to the rotation of molecules,” Mart said. “When the molecule is in solution, it moves and is constantly rotating. When it’s very small, it rotates very fast and the anisotropy is nearly zero.
“But when the same probe binds to a big macromolecule, it rotates more slowly,” he said. “That’s how we know we have oligomers, and then we can track their growth and propagation.”
Lab tests showed oligomers forming in solution at different temperatures over hours. Mart noted cold solutions slow the process, but at body temperatures, oligomers form “very fast and in large amounts. The speed at which they form at physiological temperatures is remarkable.”
The Rice lab also used its probes to see how neuroblastoma cells were affected in real time when injected with amyloid beta peptides. They revealed only 60% of cells injected with oligomers remained viable, while those treated with amyloid fibrils and monomers had higher viability, about 80%, suggesting the oligomers are indeed toxic, Mart said.
For now, he said, the ruthenium probes are meant for use only in the laboratory. “It will be difficult to use these in the brain because there’s too much scattering of light,” Mart said. “They are made to take advantage of polarized light, and scattering would dampen that.
“But as a lab tool, they will allow researchers around the world to test the effects of other molecules on the rate of oligomer formation, and that’s a big deal,” he said. “They can quickly see if a drug delays or halts the formation of oligomers.”
Rice graduate student Bo Jiang is lead author of the paper. Co-authors are Rice graduate student Ashleigh Smith McWilliams; undergraduate Andrea Augustine; Rice alumni Nathan Cook, now an instrumentation specialist in the Department of Chemistry at Williams College in Williamstown, Massachusetts, Amir Aliyan, now a researchers at Khatam University in Tehran, Iran, and Rodrigo Maldonado, now a graduate student at Northwestern University; Ghibom Bhak and Javier Montenegro of the Universidade de Santiago de Compostela, Spain; Erick Flores and Fernando Godoy of the Universidad de Santiago de Chile; and Nicolas Mendez, Mohammad Shahnawaz and Ines Moreno-Gonzalez of The University of Texas Health Science Center at Houston.
The Welch Foundation supported the research.
####
About Rice University
Located on a 300-acre forested campus in Houston, Rice University is consistently ranked among the nations top 20 universities by U.S. News & World Report. Rice has highly respected schools of Architecture, Business, Continuing Studies, Engineering, Humanities, Music, Natural Sciences and Social Sciences and is home to the Baker Institute for Public Policy. With 3,962 undergraduates and 3,027 graduate students, Rices undergraduate student-to-faculty ratio is just under 6-to-1. Its residential college system builds close-knit communities and lifelong friendships, just one reason why Rice is ranked No. 1 for lots of race/class interaction and No. 4 for quality of life by the Princeton Review. Rice is also rated as a best value among private universities by Kiplingers Personal Finance.
Follow Rice News and Media Relations via Twitter @RiceUNews.
For more information, please click here
Contacts:
Jeff Falk
713-348-6775
Mike Williams
713-348-6728
Copyright © Rice University
If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Molecules ‘light up’ Alzheimer’s roots:
Wiess School of Natural Sciences:
News and information
Arrowhead Pharmaceuticals to Participate in Upcoming October 2019 Conferences October 1st, 2019
Borophene on silver grows freely into an atomic skin: Rice scientists lead effort to improve manufacture of valuable 2D material October 1st, 2019
New design of bioactive peptide nanofibers keeping both temperature reversibility and stiffness control September 30th, 2019
Possible Futures
Arrowhead Pharmaceuticals to Participate in Upcoming October 2019 Conferences October 1st, 2019
Borophene on silver grows freely into an atomic skin: Rice scientists lead effort to improve manufacture of valuable 2D material October 1st, 2019
New design of bioactive peptide nanofibers keeping both temperature reversibility and stiffness control September 30th, 2019
Novel nanogels hold promise for improved drug delivery to cancer patients: ‘Precision Medicine’ approach underpins UT Austin engineers’ development of multifunctional nanogel September 27th, 2019
Nanomedicine
Arrowhead Pharmaceuticals to Participate in Upcoming October 2019 Conferences October 1st, 2019
New design of bioactive peptide nanofibers keeping both temperature reversibility and stiffness control September 30th, 2019
Novel nanogels hold promise for improved drug delivery to cancer patients: ‘Precision Medicine’ approach underpins UT Austin engineers’ development of multifunctional nanogel September 27th, 2019
Tiny, biocompatible laser could function inside living tissues: Nanolaser has potential to treat neurological disorders or sense disease biomarkers September 23rd, 2019
Discoveries
Borophene on silver grows freely into an atomic skin: Rice scientists lead effort to improve manufacture of valuable 2D material October 1st, 2019
New design of bioactive peptide nanofibers keeping both temperature reversibility and stiffness control September 30th, 2019
CCNY physicists score double hit in LED research September 27th, 2019
Novel nanogels hold promise for improved drug delivery to cancer patients: ‘Precision Medicine’ approach underpins UT Austin engineers’ development of multifunctional nanogel September 27th, 2019
Announcements
Arrowhead Pharmaceuticals to Participate in Upcoming October 2019 Conferences October 1st, 2019
Borophene on silver grows freely into an atomic skin: Rice scientists lead effort to improve manufacture of valuable 2D material October 1st, 2019
New design of bioactive peptide nanofibers keeping both temperature reversibility and stiffness control September 30th, 2019
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers
Borophene on silver grows freely into an atomic skin: Rice scientists lead effort to improve manufacture of valuable 2D material October 1st, 2019
New design of bioactive peptide nanofibers keeping both temperature reversibility and stiffness control September 30th, 2019
Physicists found weak spots in ceramic/graphene composites: Physicists found out the structures in nanomaterials made of ceramic and graphene plates, in which cracks appear most frequently September 27th, 2019
Novel nanogels hold promise for improved drug delivery to cancer patients: ‘Precision Medicine’ approach underpins UT Austin engineers’ development of multifunctional nanogel September 27th, 2019
Grants/Sponsored Research/Awards/Scholarships/Gifts/Contests/Honors/Records
Machine learning at the quantum lab September 27th, 2019
Novel nanogels hold promise for improved drug delivery to cancer patients: ‘Precision Medicine’ approach underpins UT Austin engineers’ development of multifunctional nanogel September 27th, 2019
‘Nanochains’ could increase battery capacity, cut charging time September 20th, 2019
One-atom switch supercharges fluorescent dyes: Rice University lab discovers simple technique to make biocompatible ‘turn-on’ dyes September 13th, 2019
Nanobiotechnology
Arrowhead Pharmaceuticals to Participate in Upcoming October 2019 Conferences October 1st, 2019
New design of bioactive peptide nanofibers keeping both temperature reversibility and stiffness control September 30th, 2019
Novel nanogels hold promise for improved drug delivery to cancer patients: ‘Precision Medicine’ approach underpins UT Austin engineers’ development of multifunctional nanogel September 27th, 2019
Keystone Nano Announces FDA Approval of Investigational New Drug Application for Ceraxa for the Treatment of Acute Myeloid Leukemia September 18th, 2019